10% CONVERTIBLE PROMISSORY NOTE DUE SEPTEMBER 28, 2016Premier Biomedical Inc • December 31st, 2015 • Biological products, (no disgnostic substances) • New York
THIS 10% CONVERTIBLE PROMISSORY NOTE is one of a series of duly authorized and validly issued 10% Convertible Promissory Notes of Premier Biomedical Inc. (the "Company"), having its principal place of business at P.O. Box 31374, El Paso, TX 79930, designated as its 10% Convertible Notes due September 28, 2016 (this Note, the "Note" and, collectively with the other Notes of such series, the "Notes").
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 31st, 2015 • Premier Biomedical Inc • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this "Agreement") is dated as of December 28, 2015, between Premier Biomedical, Inc. (the "Company") and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a "Purchaser" and collectively, the "Purchasers").
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 31st, 2015 • Premier Biomedical Inc • Biological products, (no disgnostic substances)
This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the "Purchase Agreement").
